b'Gel and CapillaryResearch Use Only (RUO) AssayB-Cell AssaysT-Cell AssaysTranslocation Assays96 IGH + IGK B-Cell 106 TCRB + TCRG118 BCL1/JH TranslocationClonality Assays T-Cell Clonality Assays Assay98 IGH Gene Rearrangement108 TCRB Gene 120 BCL2/JH t(14;18) AssaysClonality AssaysTranslocation Assay 100 IGH Gene Clonality110 T-Cell Receptor Gama122 BCL2/JH TranslocationAssays Gene Rearrangement Assays 2.0 Assay102 IGK Gene Clonality 112 T-Cell Receptor Gama124 BCL2/JH t(9;22) TranslocationAssays Gene Rearrangement Assays Assays 104 IGL Gene Clonality 114 TCRG Gene 126 PML/RAR t(15;17) Assays Clonality Assays Translocation Assays116 TCRD GeneClonality AssaysMutation Assays128 IGH Somatic HypermutationAssays v2.0130 FLT3 MutationAssaysWARRANTY AND LIABILITYInvivoscribe, Inc. (Invivoscribe) is committed to providing the highest quality products. Invivoscribe warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe. Invivoscribe liability shall not exceed the purchase price of the product. Invivoscribe shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchasers laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of positive, negative, and blank controls every time a sample is tested. Ordering, acceptance, and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.NOTICE: Many of these products in the section that follows are covered by one or more of the following: European Patent Number 1549764, European Patent Number 2418287, European Patent Number 2460889, Japanese Patent Number 4708029, United States Patent 8859748, United States Patent 10280462, and related pending and future applications.All of these patents and applications are licensed exclusively to Invivoscribe, Inc.Additional patents licensed to Invivoscribe covering some of these products apply elsewhere.These products require nucleic acid amplification methods such as Polymerase Chain Reaction (PCR). No license under these patents to use amplification processes or enzymes is conveyed expressly or by implication to the purchaser by the purchase of these products.'